Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Neoplasms and DCK[original query] |
|---|
| An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients. The oncologist 2007 Jun 12 (6): 622-30. Rha Sun Young, Jeung Hei Cheul, Choi Yeon Ho, Yang Woo Ick, Yoo Jin Ho, Kim Byung Soo, Roh Jae Kyung, Chung Hyun Che |
| Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK). Drug metabolism and pharmacokinetics 2008 23 (5): 379-84. Kim Su-Ryang, Saito Yoshiro, Maekawa Keiko, Sugiyama Emiko, Kaniwa Nahoko, Ueno Hideki, Okusaka Takuji, Ikeda Masafumi, Morizane Chigusa, Yamamoto Noboru, Yoshida Teruhiko, Kamatani Naoyuki, Furuse Junji, Ishii Hiroshi, Saijo Nagahiro, Ozawa Shogo, Sawada Jun-Ic |
| Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jan 16 (1): 320-9. Okazaki Taro, Javle Milind, Tanaka Motofumi, Abbruzzese James L, Li Dongh |
| Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms. Clinical pharmacokinetics 2010 Aug 49 (8): 549-58. Sugiyama Emiko, Kaniwa Nahoko, Kim Su-Ryang, Hasegawa Ryuichi, Saito Yoshiro, Ueno Hideki, Okusaka Takuji, Ikeda Masafumi, Morizane Chigusa, Kondo Shunsuke, Yamamoto Noboru, Tamura Tomohide, Furuse Junji, Ishii Hiroshi, Yoshida Teruhiko, Saijo Nagahiro, Sawada Jun-Ic |
| Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer. Cancer 2010 Nov 116 (22): 5325-35. Tanaka Motofumi, Javle Milind, Dong Xiaoqun, Eng Cathy, Abbruzzese James L, Li Dongh |
| DNMT3A mutations in acute myeloid leukemia. The New England journal of medicine 2010 Dec 363 (25): 2424-33. Ley Timothy J, Ding Li, Walter Matthew J, McLellan Michael D, Lamprecht Tamara, Larson David E, Kandoth Cyriac, Payton Jacqueline E, Baty Jack, Welch John, Harris Christopher C, Lichti Cheryl F, Townsend R Reid, Fulton Robert S, Dooling David J, Koboldt Daniel C, Schmidt Heather, Zhang Qunyuan, Osborne John R, Lin Ling, O'Laughlin Michelle, McMichael Joshua F, Delehaunty Kim D, McGrath Sean D, Fulton Lucinda A, Magrini Vincent J, Vickery Tammi L, Hundal Jasreet, Cook Lisa L, Conyers Joshua J, Swift Gary W, Reed Jerry P, Alldredge Patricia A, Wylie Todd, Walker Jason, Kalicki Joelle, Watson Mark A, Heath Sharon, Shannon William D, Varghese Nobish, Nagarajan Rakesh, Westervelt Peter, Tomasson Michael H, Link Daniel C, Graubert Timothy A, DiPersio John F, Mardis Elaine R, Wilson Richard |
| Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin. Oncology research 2012 20 (1): 1. Ryu JS, Kim HJ, Shin ES, Nam HS, Cho JH, Lee JE |
| Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer. PloS one 2019 3 14 (2): e0212097. Sissung Tristan M, Rajan Arun, Blumenthal Gideon M, Liewehr David J, Steinberg Seth M, Berman Arlene, Giaccone Giuseppe, Figg William |
| Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia. Cancer reports (Hoboken, N.J.) 2022 11 e1744. Yunis Luz K, Linares-Ballesteros Adriana, Aponte Nelson, Barros Gisela, García Johnny, Niño Laura, Uribe Gloria, Quintero Edna, Yunis Juan |
| Frequency Distributions of Alleles and Genotypes and Lung Cancer Risk of Polymorphisms DCK, SLC29A1, and SLC29A3 in South Indian Healthy Population. Cureus 2024 11 16 (10): e71896. Devika T, Ganesapandian Mahalakshmi, K Mythili, Katiboina Srinivasa Rao, Srinivasamurthy Suresh Kumar, Biswajit Dubashi, Deepak G Shewa |
- Page last reviewed:Feb 1, 2024
- Content source: